EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress

Kangmin Yang iD, Srividya Velagapudi iD, Alexander Akhmedov iD, Simon Kraler iD, Tetiana Lapikova-Bryhinska, Martin O Schmiady, Xiaoping Wu, Leiluo Geng, Giovanni G Camici, Aimin Xu iD, Thomas F Lüscher

Cardiovascular Research · 16.10.2023 · 119 (12) · 2190-2201

DOI: 10.1093/cvr/cvad102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 04.07.2023. Verfasst von Kangmin Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Cardiology, University of Zürich, Wagistrasse 12, 8952 Schlieren, Switzerland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sino-Swiss Science and Technology Cooperation, National Natural Science Foundation of China, Swiss National Research Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Enhancing SIRT1 activity exerts beneficial cardiovascular effects. In diabetes, plasma SIRT1 levels are reduced. We aimed to investigate the therapeutic potential of chronic recombinant murine SIRT1 (rmSIRT1) supplementation to alleviate endothelial and vascular dysfunction in diabetic mice (db/db). Methods and results Left internal mammary arteries obtained from patients undergoing coronary artery bypass grafting with or without a diagnosis of diabetes were assayed for SIRT1 protein levels. Twelve-week-old male db/db mice and db/+ controls were treated with vehicle or rmSIRT1 intraperitoneally for 4 weeks, after which carotid artery pulse wave velocity (PWV) and energy expenditure/activity were assessed by ultrasound and metabolic cages, respectively. Aorta, carotid, and mesenteric arteries were isolated to determine endothelial and vascular function using the myograph system. Arteries obtained from diabetic patients had significantly lower levels of SIRT1 relative to non-diabetics. In line, aortic SIRT1 levels were reduced in db/db mice compared to db/+ mice, while rmSIRT1 supplementation restored SIRT1 levels. Mice receiving rmSIRT1 supplementation displayed increased physical activity and improved vascular compliance as reflected by reduced PWV and attenuated collagen deposition. Aorta of rmSIRT1-treated mice exhibited increased endothelial nitric oxide (eNOS) activity, while endothelium-dependent contractions of their carotid arteries were significantly decreased, with mesenteric resistance arteries showing preserved hyperpolarization. Ex vivo incubation with reactive oxygen species (ROS) scavenger Tiron and NADPH oxidase inhibitor apocynin revealed that rmSIRT1 leads to preserved vascular function by suppressing NADPH oxidase (NOX)-related ROS synthesis. Chronic rmSIRT1 treatment resulted in reduced expression of both NOX1 and NOX4, in line with a reduction in aortic protein carbonylation and plasma nitrotyrosine levels.

Conclusions

In diabetic conditions, arterial SIRT1 levels are significantly reduced. Chronic rmSIRT1 supplementation improves endothelial function and vascular compliance by enhancing eNOS activity and suppressing NOX-related oxidative stress. Thus, SIRT1 supplementation may represent novel therapeutic strategy to prevent diabetic vascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalHumansMiceMaleAnimalsReactive Oxygen SpeciesVasodilationSirtuin 1Pulse Wave AnalysisEndothelium, VascularOxidative StressNADPH OxidasesDietary SupplementsMice, Inbred C57BLNitric Oxide Synthase Type III

Stichwörter der Autor:innen

Endothelial functionNOX1–NOX4Nitric oxideReactive oxidative speciesSirtuin

Substanzen

Reactive Oxygen SpeciesSirtuin 1NADPH OxidasesNitric Oxide Synthase Type IIISIRT1 protein, human

Autor:innen und Institutionen

  • Center for Molecular Cardiology, University of Zürich, Wagistrasse 12, 8952 Schlieren, Switzerland.
  • Department of Cardiac Surgery, University Heart Center, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland.
  • State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine and Department of Pharmacology and Pharmacy, The University of Hong Kong, Sassoon Road 21, Pok Fu Lam, 000000 Hong Kong, China.
  • Department of Research and Education, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland.

ORCID-Profile: Kangmin Yang, Srividya Velagapudi, Alexander Akhmedov, Simon Kraler, Aimin Xu

Förderung

  • Sino-Swiss Science and Technology Cooperation
  • National Natural Science Foundation of China
  • Swiss National Research Science Foundation
  • Foundation for Cardiovascular Research—Zurich Heart House
  • Swiss Heart Foundation

Zitieren

APA

Yang, K., Velagapudi, S., Akhmedov, A., Kraler, S., Lapikova-Bryhinska, T., Schmiady, M. O., Wu, X., Geng, L., Camici, G. G., Xu, A., & Lüscher, T. F. (2023). Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress. Cardiovascular Research, 119(12), 2190-2201. https://doi.org/10.1093/cvr/cvad102

Vancouver

Yang K, Velagapudi S, Akhmedov A, Kraler S, Lapikova-Bryhinska T, Schmiady MO, et al. Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress. Cardiovascular Research. 2023;119(12):2190-2201. doi:10.1093/cvr/cvad102

BibTeX
@article{Yang2023,
  author = {Yang, Kangmin and Velagapudi, Srividya and Akhmedov, Alexander and Kraler, Simon and Lapikova-Bryhinska, Tetiana and Schmiady, Martin O and Wu, Xiaoping and Geng, Leiluo and Camici, Giovanni G and Xu, Aimin and Lüscher, Thomas F},
  title = {Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress},
  journal = {Cardiovascular Research},
  year = {2023},
  volume = {119},
  number = {12},
  pages = {2190--2201},
  doi = {10.1093/cvr/cvad102}
}
Kostenlos starten →